A systems approach to reducing errors in insulin therapy in the inpatient setting.

OBJECTIVE To highlight the importance of insulin-related medical errors in causing poor outcomes in a hospital setting and to propose a systems approach for improvement. RESULTS Evidence reported in the medical literature has identified insulin therapy errors as a large and clinically important problem. Insulin has been labeled as one of the top five "high-risk medications" in the inpatient setting. Although insulin therapy can be lifesaving in the hospital setting, it can be life-threatening if used inappropriately. Widespread major systemic problems, such as heavy patient loads for physicians and nurses, absence of backup checks in critical areas, defective communication and coordination, illegible handwriting, and unawareness of the importance of blood glucose control, create obstacles to appropriate and safe care of patients receiving insulin in the hospital. With thorough analysis of the setting, additional training, collective establishment of goals focused on patient safety, insertion of backup checks in areas susceptible to errors, encouragement of sharing of key clinical information, and, where possible, implementation of electronic medical records, systemic and knowledge-based problems will be minimized and outcomes will improve in insulin-treated hospitalized patients. CONCLUSION Analysis and redesign of systems to develop a "culture of safety" will ultimately reduce insulin-related medical errors, provide a safe inpatient environment, and yield better outcomes.

[1]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[2]  T. Caeiro,et al.  [Error in medicine]. , 2004, Medicina.

[3]  K. McDonald,et al.  Making health care safer: a critical analysis of patient safety practices. , 2001, Evidence report/technology assessment.

[4]  Ann Page,et al.  COMMITTEE ON THE WORK ENVIRONMENT FOR NURSES AND PATIENT SAFETY , 2004 .

[5]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[6]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[7]  D. Bates,et al.  What practices will most improve safety? Evidence-based medicine meets patient safety. , 2002, JAMA.

[8]  E. Rimon,et al.  Hypoglycemia as a predictor of mortality in hospitalized elderly patients. , 2003, Archives of internal medicine.

[9]  D. Bates,et al.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.

[10]  D. Bates,et al.  Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. , 1998, JAMA.

[11]  R. Hellman,et al.  Effect of Intensive Treatment of Diabetes on the Risk of Death or Renal Failure in NIDDM and IDDM , 1997, Diabetes Care.

[12]  C. Marano,et al.  To err is human. Building a safer health system , 2005 .

[13]  P. Aspden Patient Safety: Achieving a New Standard for Care , 2004 .

[14]  Jerry Phillips,et al.  'High-alert' medications and patient safety. , 2001, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[15]  A. Markowitz Unexpected Hypoglycemia in a Critically Ill Patient , 2002 .

[16]  H. Ben-Ami,et al.  Drug-induced hypoglycemic coma in 102 diabetic patients. , 1999, Archives of internal medicine.

[17]  J. Newman,et al.  Hypoglycemia in hospitalized patients. Causes and outcomes. , 1986, The New England journal of medicine.

[18]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[19]  D. Bates,et al.  Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.

[20]  V. Sharpe Promoting patient safety. An ethical basis for policy deliberation. , 2003, The Hastings Center report.

[21]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[22]  Margaret Edmunds,et al.  BOARD ON HEALTH CARE SERVICES INSTITUTE OF MEDICINE , 1998 .

[23]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.